Mininvasive Medical Technologies
New spin-off from MST
Mininvasive Medical Technologies is on its mission to reduce the inconveniencies of blood sampling with painless microneedle technology
Mininvasive started in 2018 as a research project at KTH Royal Institute of Technology in the Division of Micro and Nanosystems (MST), where researchers developed a painless and blood-free microsampling device for point of care and homecare applications.
Since April 2022, the project was selected to be part of the
KTH Innovation
pre-incubator program where, in parallel to the technological development, it is investigating its business potential.
To move towards this goal, Mininvasive is currently looking for a
CEO/Business Developer
who would like to join an early medtech startup and use their experience to make a difference.
Spontaneous application for co-founders and advisors who are up for a challenge and with proven experience in a relevant field (such as diagnostics and analytical chemistry, mechanical and industrial design, or regulatory in the medical sector) are also welcome to get in touch with the team.
Contact: ribet@kth.se